A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

September 26, 2025

Study Completion Date

September 26, 2025

Conditions
Advanced Solid TumorsNon-small Cell Lung Cancer
Interventions
DRUG

BAY2862789

Oral administration, solution or tablets

Trial Locations (18)

2010

The Kinghorn Cancer Centre - Medical Oncology Department, Darlinghurst

3080

Seoul National University Hospital, Seoul

4102

Princess Alexandra Hospital Australia, QLD

28644

Chungbuk National University Hospital, Cheongju-si

29010

Hospital Universitario Virgen De La Victoria - Oncology, Málaga

34747

AdventHealth medical Group Oncology Research at Celebration, Celebration

39213

Cancer Center and Research Institute - UMMC, Jackson

48202

Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit, Detroit

52727

Gyeongsang National University Hospital, Jinju

77030

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

130000

Jilin Cancer Hospital, Changchun

430030

Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech., Wuhan

6423906

Tel-Aviv Sourasky Medical Center, Tel Aviv

9112001

Hadassah Hebrew University Hospital Ein Kerem, Jerusalem

Texas

"START , San Antonio"

05505

Asan Medical Center - Oncology Department, Seoul

06591

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

08035

Hospital Universitari Vall d'Hebron - Institut d'Oncologia - Grupo de Tumores Toracicos y Cancer de Cabeza y Cuello, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05858164 - A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter